Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies

被引:224
作者
Khan, Mahmud Tareq Hassan [1 ]
Orhan, I. [2 ]
Senol, F. S. [2 ]
Kartal, M. [3 ]
Sener, B. [2 ]
Dvorska, M. [4 ]
Smejkal, K. [4 ]
Slapetova, T. [4 ]
机构
[1] Univ Tromso, Inst Med Biol, Dept Pharmacol, N-9037 Tromso, Norway
[2] Gazi Univ, Fac Pharm, Dept Pharmacognosy, TR-06330 Ankara, Turkey
[3] Ankara Univ, Fac Pharm, Dept Pharmacognosy, TR-06100 Ankara, Turkey
[4] Univ Vet & Pharmaceut Sci, Fac Pharm, Dept Nat Drugs, Brno 61242, Czech Republic
关键词
Alzheimer's disease; Acetylcholinesterase; Butyrylcholinesterase; Flavonoids; Xanthone; Molecular docking; ALZHEIMERS-DISEASE; ACTIVE-SITE; ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; THERMOLYSIN; PREDICTION; DESIGN;
D O I
10.1016/j.cbi.2009.06.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Flavonoids are one of the largest classes of plant secondary metabolites and are known to possess a number of significant biological activities for human health. In this study, we examined in vitro acetylcholinesterase (ACH) and butyrylcholinesterase (BChE) inhibitory activities of four flavonoid derivatives - quercetin, rutin, kaempferol 3-O-beta-D-galactoside and macluraxanthone. The in vitro results showed that quercetin and macluraxanthone displayed a concentration-dependant inhibition of AChE and BChE. Macluraxanthone showed to be the most potent and specific inhibitor of both the enzymes having the IC(50) values of 8.47 and 29.8 mu M, respectively. The enzyme kinetic studies revealed that quercetin inhibited both the enzymes in competitive manner, whereas the mode of inhibition of macluraxanthone was noncompetitive against AChE and competitive against BChE. The inhibitory profiles of the compounds have been compared with standard AChE inhibitor galanthamine. To get insight of the intermolecular interactions, the molecular docking studies of these two compounds were performed at the active site 3D space of both the enzymes, using ICM-Dock (TM) module. Docking studies exhibited that macluraxanthone binds much more tightly with both the enzymes than quercetin. The calculated docking and binding energies also supported the in vitro inhibitory profiles (IC(50) values). Both the compounds showed several strong hydrogen bonds to several important amino acid residues of both the enzymes. A number of hydrophobic interactions could also explain the potency of the compounds to inhibit AChE and BChE. Crown Copyright (C) 2009 Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 33 条
[1]   ICM - A NEW METHOD FOR PROTEIN MODELING AND DESIGN - APPLICATIONS TO DOCKING AND STRUCTURE PREDICTION FROM THE DISTORTED NATIVE CONFORMATION [J].
ABAGYAN, R ;
TOTROV, M ;
KUZNETSOV, D .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1994, 15 (05) :488-506
[2]   Protective effect of quercetin in primary neurons against Aβ(1-42): relevance to Alzheimer's disease [J].
Ansari, Mubeen Ahmad ;
Abdul, Hafiz Mohammad ;
Joshi, Gururaj ;
Opii, Wycliffe O. ;
Butterfield, D. Allan .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2009, 20 (04) :269-275
[3]   Conformational flexibility of the acetylcholinesterase tetramer suggested by X-ray crystallography [J].
Bourne, Y ;
Grassi, J ;
Bougis, PE ;
Marchot, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30370-30376
[4]   Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors [J].
Brühlmann, C ;
Marston, A ;
Hostesttmann, K ;
Carrupt, PA ;
Testa, B .
CHEMISTRY & BIODIVERSITY, 2004, 1 (06) :819-829
[5]  
BURAK IM, 1999, TURKIYE KLIN TIP BIL, V19, P296
[6]   Chemical studies of anthocyanins: A review [J].
Castaneda-Ovando, Araceli ;
de Lourdes Pacheco-Hernandez, Ma ;
Elena Paez-Hernandez, Ma. ;
Rodriguez, Jose A. ;
Andres Galan-Vidal, Carlos .
FOOD CHEMISTRY, 2009, 113 (04) :859-871
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   Docking and quantum mechanic studies on cholinesterases and their inhibitors [J].
Correa-Basurto, Jose ;
Flores-Sandoval, Cesar ;
Marin-Cruz, Jesus ;
Rojo-Dominguez, Arturo ;
Espinoza-Fonseca, L. Michel ;
Trujillo-Ferrara, Jose G. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (01) :10-19
[9]  
Dajas F., 2005, Current Neuropharmacology, V3, P193, DOI 10.2174/1570159054368303
[10]   Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase [J].
Decker, Michael .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (18) :5411-5413